Siemens Healthcare Diagnostics, Inc. recalls DCA Systems HbA1c Reagent Kit
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- The reason for the recall is that the Siemens DCA HbA1c Reagent Kit was confirmed to display a positive bias without alerting the user. The potential impact of the defect is that erroneous test results could be reported and potentially lead to incorrect patient management of glucose control. A positive bias may be observed with eleven HbA1c affected lots. Positive bias was observed when the performance of these five HbA1c lots was compared to NGSP pooled patient target-value assigned samples and the maximum bias observed was 19%.
- Products
-
- DCA Systems HbA1c Reagent Kit
- Where it was sold
-
Worldwide distribution - US Nationwide and the country of Taiwan.
Nationwide
- Barcodes
00630414532806- Units affected
- 74,211 Kits (Expanded 2/28/24: additional 72,892 kits)
- About this recall
- DCA Systems HbA1c Reagent Kit